
Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Steven Fuller, PhD, is chief operating officer at Panacea Pharmaceuticals.
Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Published: September 15th 2017 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.